Wuhan PS Information Tech

Liyuan Information repurchased 600,000 shares of the company for the first time through centralized bidding on August 12. This repurchase accounts for 0.0522% of the company's current total share capital, with the lowest transaction price at 12.64 yuan per share and the highest at 12.73 yuan per share, totaling 7.62 million yuan including transaction fees. The company stated that this repurchase complies with the share repurchase plan and relevant laws and regulations.

Talkweb Information System released its 2026 semi-annual report, achieving operating revenue of 1.312 billion yuan, up 0.39% year-on-year, with net profit attributable to shareholders of the listed company at 69.222 million yuan, down 12.16% year-on-year. The company plans to distribute a cash dividend of 0.25 yuan for every 10 shares to all shareholders. As of the end of the reporting period, the company had over 30 products certified through OpenHarmony compatibility assessment, with related products in the market expansion and application stage. In other news, WuXi AppTec announced that a U.S. court has granted its preliminary injunction motion, shielding the company from immediate adverse impact while it challenges the U.S. Department of Defense's 1260H designation in judicial proceedings. Gaozheng Explosives' controlling shareholder is set to change to Tibet Geology and Mineral Resources Group. Ningxia Building Materials plans to repurchase shares worth 100 million to 200 million yuan for cancellation. Wuhan P&S Information Technology saw semi-annual net profit surge 209.5% year-on-year. Galaxy Microelectronics' semi-annual net profit rose 77.28% year-on-year. Hongte Technology plans to raise no more than 650 million yuan through a rights issue for its Thailand base and other projects. Tuoxin Pharmaceutical plans to raise no more than 228 million yuan through a private placement of shares. Biolight has terminated the planned change of control, and its shares and convertible bonds will resume trading on August 10. Huadong Medicine's wholly-owned subsidiary obtained EU MDR CE certification for its medical aesthetics product. Jumpcan Pharmaceutical's subsidiary obtained drug registration certificates for pediatric laxative granules and mesalazine sustained-release granules. Chinese Health's wholly-owned subsidiary had its drug registration application for ferrous succinate tablets accepted.

Liyuan Information has released its semi-annual report, showing net profit attributable to shareholders of the listed company for the first half of 2026 reached 298 million yuan, a year-on-year increase of 209.5%. The company achieved operating revenue of 6.432 billion yuan over the same period, up 59.46% year-on-year, with basic earnings per share of 0.2585 yuan. The revenue growth was mainly driven by favorable market conditions, significant growth in businesses such as AI, industrial and new energy, and automotive electronics, as well as the development of new customers.

Liyuan Information announced that it has recently obtained a loan commitment letter from the Wuhan branch of China CITIC Bank. The loan amount is capped at 27 million yuan and no more than 90 percent of the actual repurchase amount, with a term of up to two years. The loan is exclusively for the company's stock repurchase.

Liyuan Information has disclosed its earnings forecast, expecting to achieve operating revenue of 6.44 billion yuan in the first half of 2026, a year-on-year increase of 60%. Net profit attributable to the parent company is expected to be between 295 million and 305 million yuan, a year-on-year increase of 206.87% to 217.28%. Deducted non-recurring net profit is expected to be between 297 million and 307 million yuan, a year-on-year increase of 226.39% to 237.38%. The company stated that the significant growth in performance is mainly due to the rapid development of AI technology driving increased demand for related computing power. Demand from previously cultivated top-tier customers in AI power supplies, optical modules, servers, GPUs, and computing cards has surged, with sales revenue from the AI industry business increasing by over 150%. Sales revenue from the industrial and new energy business also doubled. In the automotive electronics business, sales revenue from automotive customers nearly doubled in the first half of the year, and sales of silicon carbide products increased several-fold. In addition, sales of various memory chips distributed by the company also saw substantial growth. The impact of non-recurring gains and losses on net profit for the first half of 2026 is approximately negative 2.2088 million yuan, compared with 5.1355 million yuan in the same period last year.